newsfilter
← Latest News
GlobeNewswire·

First Patient Dosed in Small Pharma's Drug Interaction Study

LONDON, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health